NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel carbohydrate therapeutic compounds, today announced that David Platt, Ph.D., Chief Executive Officer of Pro-Pharmaceuticals, Inc., is scheduled to present a corporate overview and update on Wednesday, October 18 at 3:20 p.m. (Pacific Time) at the BIO Investor Forum at the Palace Hotel in San Francisco, California.
